RE:RE:RE:thoughtsI'm almost auto-catatonic myself! Hahaha!!
I mentioned some time ago that I thought Reliq had, with a high degree of probability, turned a fundamental corner and it was only a matter of time...
Of course, many here claimed that only audited results would move the needle. Well, like most things, that opinion worked, until it didn't.
Also, one particular poster has become more and more negative as the price goes up. That's on top of his usual grude match with the share count, managment competence, etc. Lots of name calling and general venting. Thankfully, the ignore button is a great restorative.
Thanks to Lifeboat1 and others for their sage comments. Regards...i22
prophetoffacts wrote: Told ya!!
"1. short term catalysts have been priced in the current share price"
Not priced in. The biggest catalyst of all is undervaluation. The 200,000 patients is backward-looking and nowhere near priced in. Lisa has essentially said that they are a done deal which mean little should be needed in terms of a discount. There is nothing priced in for more than 200,000 patients despite demand for RHT's technology having reached the auto-catalytic stage and the size of the addressable market. RHT is routinely adding new clients. Lisa said in the interview there is lots of inbound calls. In other words, 200,000 patients is a minumum. Deals at this stage can also be bigger as RHT's resume strengthens. Again demand is now at the auto-catalytic stage. During the interview Lisa also said she was talking with Oppenheimer. The bids and volume on this stock also suggest a new level of interest. Lisa paints an almost perfect picture for what's to come.